Age at diagnosis (days), median [IQR] |
154.0 [32.0, 510.5] |
49.5 [10.8, 150.8] |
293.0 [96.0, 794.0] |
<0.001 |
Age at treatment initiation (days), median [IQR] |
159.5 [34.5,
539.8] |
48.0 [18.0, 156.0] |
300.00[125.0, 1016.0] |
<0.001 |
Female Sex, n (%) |
61 (38.4%) |
22 (34.4%) |
39 (41.1%) |
0.4 |
Diagnosis confirmed by biopsy, n (%) |
133 (83.7%) |
46 (71.9%) |
87
(91.6%) |
0.002 |
Tumor Location, n (%)
Truncal
Non-truncal
Other
|
46 (28.9%)
94 (59.1%)
19 (12.0%)
|
26 (40.6%)
32 (50.0%)
6 (9.4%)
|
20 (21.1%)
62 (65.3%)
13 (13.7%)
|
0.029
|
Tumor Size, n (%)
< 5cm
≥ 5cm
Unmeasured/unknown
|
50 (31.5%)
95 (59.8%)
14 (8.8%)
|
7 (10.9%)
53 (82.8%)
4 (6.3%)
|
43 (45.3%)
42 (44.2%)
10 (10.5%)
|
<0.001
|
Tumor Extent, n (%)
Localized/well-circumscribed or superficial
(<3cm)
Localized but not well-circumscribed,
infiltrative (>3cm)
Extensive across 1 body area
Extensive, involving more than 1 body area
Multifocal
Other
|
21 (13.2%)
66 (41.5%)
40 (25.2%)
28 (17.6%)
2 (1.3%)
2 (1.3%)
|
0 (0%)
23 (35.9%)
19 (29.7%)
20 (31.3%)
0 (0%)
2 (3.1%)
|
21 (22.1%)
43 (45.3%)
21 (22.1%)
8 (8.4%)
2 (2.1%)
0 (0%)
|
<0.001
|
Presence of Coagulopathy at Diagnosis, n (%) |
65 (40.9%) |
51
(79.7%) |
14 (14.7%) |
<0.001 |
≥ 1 Hospitalizations, n (%) |
45 (28.3%) |
27 (42.2%) |
18 (19.0%) |
<0.001 |
Hospital Length of Stay (days), median [IQR] |
2.0 [0.0, 11.0] |
13.5 [5.0, 30.5] |
0.0 [0.0, 2.0] |
<0.001 |
Length of ICU Stay (days), median [IQR] |
0.0 [0.0, 3.0] |
4.0
[0.0, 16.0] |
0.0 [0.0, 0.0] |
<0.001 |
Deceased, n (%) |
2 (1.3%) |
2 (3.1%) |
0 (0%) |
0.2 |